Ignite Creation Date:
2024-05-06 @ 2:52 AM
Last Modification Date:
2024-10-26 @ 11:24 AM
Study NCT ID:
NCT02145468
Status:
COMPLETED
Last Update Posted:
2017-06-02
First Post:
2014-05-15
Brief Title:
A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo LATITUDE-TIMI 60
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-06-03
Start Date Type:
ACTUAL
Primary Completion Date:
2015-12-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12-14
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-15
First Submit QC Date:
May 20 2014
Study First Post Date:
2014-05-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2017-06-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2016-03-17
Disp First Submit QC Date:
March 17 2016
Disp First Post Date:
2016-04-15
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-04-27
Last Update Post Date:
2017-06-02
Last Update Post Date Type:
ACTUAL